Home Sitemap Contact Welcome to BOC India Ltd.
About Us
Business Areas
Electronics Gases
Industrial Gases
Shielding Gases
  Products
  Product Selection Guide
  Industries/Applications
  Case Studies
  Why BOC
  Enquiry Form
  BOC Capabilities
  Product Groups
  Delivery Options
  Enquiry Form
  Safety Data Sheet
Medical Gases
Products
  Delivery Options
  Reduce your costs
  Breathe fresh air
  Case Studies
  Enquiry Form
Speciality Gases
BOC Capabilities
  Product Groups
  Industries/Applications
  Case Studies
  Customer Section
  Enquiry Form
Projects
Market Areas Served
  Product
  Case Studies
  Resources
  Enquiry Form
Career
Why BOC?
BOC News
Environmental Policy
BOC Capabilities
Case Studies
Download Centre
Events @ BOC
 
 
 
 
Reduce Your Costs
Increase your life and Reduce costs
BOC Oxygen therapy solutions can reduce costs by more than 40%
Increasing ageing population; Rising healthcare costs; Preparedness of hospitals to release patients earlier; Psychological feeling of well being while recovering at home;

All these and more have increased the need for domiciliary long-term oxygen therapy. Combined results of MRC and NOTT clearly indicate that, after 4 to 5 years of oxygen therapy, the probability of survival increases from approx. 40% to 80% as one moves from zero to 19 hours per day of oxygen use. Some of the reasons are:
Improves oxygen delivery to vital organs
Reduces breathlessness
Reduces workloads on hearts
Improves energy levels
Helps in migraines, sleep disorders, headaches caused by oxygen deficiency in the blood
But oxygen therapy could be expensive.....
At an average flow rate of 3L per min and 10 hour daily usage, the annual therapy cost of oxygen through cylinders would be approx. Rs. 65,000.
Oxygen Concentrators is the answer – your annual costs would reduce by more than 40%.
 
Back Print
 
 
Top Links
News
Investor Relation
Environment Policy
 
For Product & Service Queries
1800 345 6789 (Toll Free)
+91 33 30411500
 
Download
 
Business Queries
 
Copyright © 2010 BOC India Limited. A Member of The Linde Group. Best viewed in IE & Firefox.